about
Antibody Recognition and Neutralization Determinants on Domains I and II of West Nile Virus Envelope ProteinType- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent EpitopesDengue virus neutralization is modulated by IgG antibody subclass and Fcγ receptor subtypeThe Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteinsMosquito bite delivery of dengue virus enhances immunogenicity and pathogenesis in humanized mice.In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection.Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2.The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope proteinTherapeutic efficacy of antibodies lacking Fcγ receptor binding against lethal dengue virus infection is due to neutralizing potency and blocking of enhancing antibodies [corrected].Functional analysis of antibodies against dengue virus type 4 reveals strain-dependent epitope exposure that impacts neutralization and protection.The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity.Genotype-specific neutralization and protection by antibodies against dengue virus type 3.On a mouse monoclonal antibody that neutralizes all four dengue virus serotypes.Protection by immunoglobulin dual-affinity retargeting antibodies against dengue virus.The Haemophilus influenzae Type b hcsA and hcsB gene products facilitate transport of capsular polysaccharide across the outer membrane and are essential for virulence.
P50
Q27477718-E91AB2E6-451C-4C21-BD7D-B6D540F3F232Q27485031-7A820A4A-DB42-4846-A799-717C6D972B25Q27490436-DD89E535-FFC0-4A82-82EB-0A802EC30326Q27491317-8D1AEF1E-92D9-471C-BC4D-6011B3193CEEQ27649830-33271EBA-1D34-46E8-B897-CC96333ECF50Q33401149-AFAD430D-B38E-47C1-8757-A42DA7A7C6D4Q33945441-07EDB3DC-DCBE-41F9-966F-BE36EEF9AE6CQ34120070-27192C13-8E9D-4F31-8925-DECF32646B72Q34386384-6F1BD053-A1C1-4949-AB83-31C4FE43DA08Q34607919-F6D8A933-8637-42CC-95B9-B89C96E87B20Q37123259-A98923F6-1005-49E8-B10B-1A4A7CEAE4F2Q37448171-80049E91-BDE3-4854-9171-16B252B5DACEQ39668466-8C81B07C-C8BB-4F2D-AB33-954C28B8503AQ39876628-A9DBFDED-EC5A-4D31-9840-5958E988F0F6Q40248409-B363379D-BF85-4715-9A6F-272ED69B41E8Q41671591-FC836C8F-4B82-472B-B2D8-720C8F12506F
P50
description
onderzoeker
@nl
name
Soila Sukupolvi-Petty
@ast
Soila Sukupolvi-Petty
@en
Soila Sukupolvi-Petty
@es
Soila Sukupolvi-Petty
@nl
Soila Sukupolvi-Petty
@sl
type
label
Soila Sukupolvi-Petty
@ast
Soila Sukupolvi-Petty
@en
Soila Sukupolvi-Petty
@es
Soila Sukupolvi-Petty
@nl
Soila Sukupolvi-Petty
@sl
prefLabel
Soila Sukupolvi-Petty
@ast
Soila Sukupolvi-Petty
@en
Soila Sukupolvi-Petty
@es
Soila Sukupolvi-Petty
@nl
Soila Sukupolvi-Petty
@sl